Company
InFarmatik - founded in 1994 by Dr. Laszlo Kovacs - offers a continuously growing collection of non-exclusive building blocks, scaffolds and advanced intermediates. Its diverse portfolio includes a wide range of compounds from benzodiazepines through modern TOSMIC building blocks to unique structures. The scaffolds are designed to provide convenient starting materials for drug molecules in therapeutic applications for CNS and oncology and inhibitors zinc coordinating enzymes (MMPs, ADAMs).. InFarmatik follows an aggressive synthetic method development strategy employing its proprietary thermal gradient platform.